|drug3812||daily syndromic surveillance Wiki||1.00|
|drug1769||Ketogenic diet Wiki||0.71|
|drug4087||standard of care Wiki||0.58|
There is one clinical trial.
The purpose of this research is to collect information about coronavirus exposures, symptoms, and health care visits due to the among Atrium Health clients and health care workers. Participation in this study will involve completing a daily questionnaire which covers participants coronavirus illness history or symptoms, health care seeking behaviors and treatments, contact with other sick people, and for health care workers, their use of personal protective equipment.
Description: Percent of volunteers who are 2019-nCoV Ab test positiveMeasure: Seroprevalence of SARS-CoV-2 infection in the general population of North Carolina Time: baseline
Description: Percent of volunteers who are 2019-nCoV Ab test positiveMeasure: Seroprevalence of SARS-CoV-2 infection among health care workers of North Carolina Time: baseline
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports